Ownership history in Frazier Life Sciences Management, L.P. · 7 quarters on record
This page tracks every 13F SEC filing in which Frazier Life Sciences Management, L.P. reported a position in ADVERUM BIOTECHNOLOGIES INC (ADVM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 2,077,431 | +1,008,187 | +94.3% | 0.28% | $9.4M | — |
| 2025 Q2 | UNCHANGED | 1,069,244 | — | 0% | 0.09% | $2.3M | — |
| 2025 Q1 | UNCHANGED | 1,069,244 | — | 0% | 0.21% | $4.7M | — |
| 2024 Q4 | UNCHANGED | 1,069,244 | — | 0% | 0.21% | $5.0M | — |
| 2024 Q3 | UNCHANGED | 1,069,244 | — | 0% | 0.30% | $7.5M | — |
| 2024 Q2 | UNCHANGED | 1,069,244 | — | 0% | 0.34% | $7.3M | — |
| 2024 Q1 | INITIATED | 1,069,244 | — | — | 0.64% | $15.1M | — |
As of 2025 Q3 — sorted by position size